JNJ-SELL strategy 9 hourly KagiThis share is negative at the moment, and it is possible to see a test of the BUY zone area $ 151.00 - $ 145.00.
Strategy SELL current $ 160-165 and take profit near $ 145.00
Key stats
About Johnson & Johnson
Sector
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
Founded
1887
ISIN
ARDEUT112687
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
$JNJ with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:JNJ after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.
Bullish on JNJHello All!
JNJ looks like it could make a new high. The confluences I like are: JNJ made a high on the daily, retraced back to 159.00 creating a new Higher Low. Considering that price didn't break structure to the downside, and reversed in the 78.6% Fib indicates to me that price may be heading up.
$JNJ Balls to the WallAs we can see, NYSE:JNJ has been following a regular down trend April 2022 and has no significant move to break upwards until recently.
On the monthly chart, we have a solid sideways consolidation after a strong movement up indicating the possibility monthly demand.
Considering the strong bull
JOHNSON & JOHNSON Excellent confirmed sell signalJohnson & Johnson (JNJ) gave us the most optimal buy entry on our last call (April 17, see chart below) and easily hit our 157.50 Target:
Having been rejected early in September exactly at the top (Lower Highs trend-line) of the 2-year Channel Down and now establishing price action below its 1D
Bear for Johnson & Johnson confluence & fundamental
bear for the sell; technical analysis and fundamental is very important, when doing top down analysis and your confluences add up you pretty much knows what the chart going to do.
NEW RELEASE:The 3 Step Rocket Booster StrategyYes its been a while since you saw me talking about
my #1 favourite strategy of all time.
This strategy is very simple and easy to follow
-
And in this article am going to teach it to you.
Because it only has 3 steps, according to this
stock NYSE:JNJ
-
-The price has to be above the 50 EMA
-
JNJ-SELL strategy 3-Daily chart Heikin AshiI feel this share is coming under pressure, its overbought and turning negative.
Strategy SELL @ $ 163-165 and take profit near $ 150.00. SL based on personal risk parameters.
JNJ LongDemand Zone
Long 152.40
Stop 145
Target 162, 173
Risk management is much more important than a good entry point.
I am not a PRO trader.
In my trading plan, the Max Risk of each short term trade should be less than 1% of an account.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where DJN3D is featured.
